PT  - JOURNAL ARTICLE
AU  - Li, YanHui
AU  - Zhou, Chuanyang
AU  - Yang, Liming
AU  - Tan, Lei
TI  - Differential Causal Effects of Type 1 and Type 2 Diabetes on Osteomyelitis Risk: Insights from Mendelian Randomization Analysis
AID  - 10.1101/2024.04.08.24305482
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.04.08.24305482
4099  - http://medrxiv.org/content/early/2024/04/10/2024.04.08.24305482.short
4100  - http://medrxiv.org/content/early/2024/04/10/2024.04.08.24305482.full
AB  - Background Osteomyelitis (OM) poses a significant clinical challenge, especially among individuals with diabetes mellitus (DM). While both type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM) have been linked to an elevated risk of OM, the precise causal relationships remain uncertain.Methods We conducted Mendelian randomization (MR) analyses using summary statistics from genome-wide association studies (GWAS) to explore the causal effects of T1DM, T2DM, their complications, and glycemic traits on OM risk. The study utilized the inverse variance weighted (IVW) method, along with weighted median and MR-Egger for causal estimation, and performed various sensitivity analyses to ensure robustness. Multivariable MR (MVMR) analysis assessed direct effects, while two-step mediation MR analyses investigated the mediating role of DM between rheumatoid arthritis (RA) and OM.Results The MR analysis unveiled distinct causal effects of T1DM and T2DM on OM risk. Genetically determined T2DM, rather than its complications, significantly increased OM risk (primary dataset: IVW: OR = 1.13, 95% CI 1.056–1.209, p = 4E-04; validation dataset: IVW: OR = 1.317, 95% CI 1.14–1.522, p =2E-04; Meta-analysis: OR=1.206; 95% CI 1.037–1.402; p=0.014), with no observable heterogeneity or horizontal pleiotropy. MVMR analysis confirmed the robustness of the causal association between T2DM and OM, even after adjusting for potential confounders such as body mass index. Conversely, T1DM and its complications showed no significant causal link with OM in either the primary dataset (IVW: p = 0.071), the validation dataset (IVW: p = 0.276), or the meta-analysis (IVW: p = 0.242). Additionally, there was no robust evidence supporting the causal risk of glycemic traits on OM. Mediation MR analysis underscored T2DM as a pivotal contributor to the differential effects of RA on OM.Conclusions Mendelian randomization analysis provides compelling evidence of a significant causal relationship between genetically determined T2DM and increased OM risk, while T1DM exhibits distinct causal effects. Additionally, our findings highlight the role of T2DM in mediating the association between RA and OM. Further research is warranted to elucidate the underlying mechanisms and guide targeted interventions for OM prevention and management in diabetic populations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe thank the Jilin Province Science and Technology Development Grant (grant Nos. 20210101452JC and YDZJ202301ZYTS096) for funding this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study used openly available human data that were originally located at:https://www.finngen.fi/en/access_results, https://gwas.mrcieu.ac.uk/I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors https://www.finngen.fi/en/access_results https://gwas.mrcieu.ac.uk/ https://www.ebi.ac.uk/gwas/home T1DMtype 1 diabetes mellitusT2DMtype 2 diabetes mellitusOMosteomyelitisIVWInverse variance weightedIVsInstrumental variablesSNPsSingle Nucleotide PolymorphismsUVMRUnivariable MRMVMRMultivariable MROROdds ratioCIconfidence intervalGWASGenome-Wide Association StudyUKBBUnited Kingdom Biobank